NZ240261A - 1-(3,4-dihydro-2-oxo-1h-quinolin-6-yl)-2-(4-(2-phenylethyl)piperidin-1-yl)-ethanol or -ethanone and pharmaceutical compositions - Google Patents
1-(3,4-dihydro-2-oxo-1h-quinolin-6-yl)-2-(4-(2-phenylethyl)piperidin-1-yl)-ethanol or -ethanone and pharmaceutical compositionsInfo
- Publication number
- NZ240261A NZ240261A NZ240261A NZ24026191A NZ240261A NZ 240261 A NZ240261 A NZ 240261A NZ 240261 A NZ240261 A NZ 240261A NZ 24026191 A NZ24026191 A NZ 24026191A NZ 240261 A NZ240261 A NZ 240261A
- Authority
- NZ
- New Zealand
- Prior art keywords
- ethanone
- quinolin
- piperidin
- phenylethyl
- dihydro
- Prior art date
Links
- BTDIVWPGUJOXBY-UHFFFAOYSA-N 6-[1-hydroxy-2-[4-(2-phenylethyl)piperidin-1-yl]ethyl]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1C(O)CN(CC1)CCC1CCC1=CC=CC=C1 BTDIVWPGUJOXBY-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9012872A FR2668149B1 (fr) | 1990-10-18 | 1990-10-18 | Le 1-(3,4-dihydro-2-oxo-1h-quinolein-6-yl)-2-[4-(2-phenyl-ethyl)piperidin-1-yl]ethanol, sa preparation et son application en therapeutique. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ240261A true NZ240261A (en) | 1993-01-27 |
Family
ID=9401336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ240261A NZ240261A (en) | 1990-10-18 | 1991-10-17 | 1-(3,4-dihydro-2-oxo-1h-quinolin-6-yl)-2-(4-(2-phenylethyl)piperidin-1-yl)-ethanol or -ethanone and pharmaceutical compositions |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5212181A (xx) |
| EP (1) | EP0481853A1 (xx) |
| JP (1) | JPH04257579A (xx) |
| KR (1) | KR920008029A (xx) |
| AU (1) | AU638173B2 (xx) |
| CA (1) | CA2052760A1 (xx) |
| CS (1) | CS315291A3 (xx) |
| FI (1) | FI914906A (xx) |
| FR (1) | FR2668149B1 (xx) |
| HU (1) | HUT59391A (xx) |
| IE (1) | IE913653A1 (xx) |
| IL (1) | IL99779A0 (xx) |
| MX (1) | MX9101604A (xx) |
| NO (1) | NO914071L (xx) |
| NZ (1) | NZ240261A (xx) |
| PL (1) | PL292089A1 (xx) |
| PT (1) | PT99247A (xx) |
| ZA (1) | ZA918293B (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0524846A1 (fr) * | 1991-06-27 | 1993-01-27 | Synthelabo | Dérivés de 2-(pipéridin-1-y1) éthanol, leur préparation et leur application en thérapeutique |
| US6255322B1 (en) * | 1992-06-19 | 2001-07-03 | Pfizer Inc. | 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents |
| JP2686887B2 (ja) * | 1992-08-11 | 1997-12-08 | キッセイ薬品工業株式会社 | ピペリジノ−３，４−ジヒドロカルボスチリル誘導体 |
| FR2699534B1 (fr) * | 1992-12-21 | 1995-02-03 | Synthelabo | Dérivés de alpha-thiényl-pipéridine-1-éthanol, leur préparation et leur application en thérapeutique. |
| ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
| ZA9610736B (en) | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
| ZA9610741B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| AU7474998A (en) * | 1997-05-07 | 1998-11-27 | Emory University | Haloisoquinoline carboxamide |
| WO2004011430A1 (ja) * | 2002-07-25 | 2004-02-05 | Yamanouchi Pharmaceutical Co., Ltd. | ナトリウムチャネル阻害剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
| FR2640266B2 (fr) * | 1988-07-12 | 1992-07-10 | Synthelabo | Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique |
-
1990
- 1990-10-18 FR FR9012872A patent/FR2668149B1/fr not_active Expired - Fee Related
-
1991
- 1991-10-11 EP EP91402716A patent/EP0481853A1/fr not_active Withdrawn
- 1991-10-15 MX MX9101604A patent/MX9101604A/es unknown
- 1991-10-16 US US07/777,176 patent/US5212181A/en not_active Expired - Fee Related
- 1991-10-16 HU HU913267A patent/HUT59391A/hu unknown
- 1991-10-16 PT PT99247A patent/PT99247A/pt not_active Application Discontinuation
- 1991-10-17 ZA ZA918293A patent/ZA918293B/xx unknown
- 1991-10-17 PL PL29208991A patent/PL292089A1/xx unknown
- 1991-10-17 NO NO91914071A patent/NO914071L/no unknown
- 1991-10-17 CA CA002052760A patent/CA2052760A1/en not_active Abandoned
- 1991-10-17 AU AU85892/91A patent/AU638173B2/en not_active Ceased
- 1991-10-17 IL IL99779A patent/IL99779A0/xx unknown
- 1991-10-17 CS CS913152A patent/CS315291A3/cs unknown
- 1991-10-17 IE IE365391A patent/IE913653A1/en not_active Application Discontinuation
- 1991-10-17 NZ NZ240261A patent/NZ240261A/xx unknown
- 1991-10-17 JP JP3269286A patent/JPH04257579A/ja active Pending
- 1991-10-17 FI FI914906A patent/FI914906A/fi unknown
- 1991-10-17 KR KR1019910018300A patent/KR920008029A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2668149A1 (fr) | 1992-04-24 |
| NO914071D0 (no) | 1991-10-17 |
| AU638173B2 (en) | 1993-06-17 |
| IE913653A1 (en) | 1992-04-22 |
| US5212181A (en) | 1993-05-18 |
| AU8589291A (en) | 1992-04-30 |
| HUT59391A (en) | 1992-05-28 |
| JPH04257579A (ja) | 1992-09-11 |
| NO914071L (no) | 1992-04-21 |
| EP0481853A1 (fr) | 1992-04-22 |
| IL99779A0 (en) | 1992-08-18 |
| FR2668149B1 (fr) | 1994-09-23 |
| FI914906A0 (fi) | 1991-10-17 |
| FI914906A (fi) | 1992-04-19 |
| PT99247A (pt) | 1992-08-31 |
| ZA918293B (en) | 1992-07-29 |
| HU913267D0 (en) | 1992-01-28 |
| CS315291A3 (en) | 1992-05-13 |
| CA2052760A1 (en) | 1992-04-19 |
| KR920008029A (ko) | 1992-05-27 |
| MX9101604A (es) | 1992-06-05 |
| PL292089A1 (en) | 1992-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0003217A3 (en) | Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and pharmaceutical compositions containing them | |
| NZ235242A (en) | 1-cycloalkyl piperidines and pharmaceutical compositions | |
| IL99073A0 (en) | 4-substituted piperidines,process for their preparation and pharmaceutical compositions containing them | |
| HUT62559A (en) | Process for producing 1 alpha-hydroxy-d4-vitamins and pharmaceutical compositions comprising same | |
| NZ238288A (en) | Pyrazolo- and triazolo-(1,3,5)triazine derivatives; processes and pharmaceutical compositions | |
| IL135366A0 (en) | Substituted benzoxazoles and pharmaceutical compositions containing the same | |
| NZ325845A (en) | 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives, preparation and pharmaceutical use thereof | |
| IL99030A0 (en) | 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL99074A0 (en) | 3-substituted piperidines,process for their preparation and pharmaceutical compositions containing them | |
| MX9203505A (es) | N-aril-n-(4-(1-alquilheterociclico)-piperidinil) amidas y composicines farmaceuticas y metodos que emplean dichos compuestos. | |
| NZ240261A (en) | 1-(3,4-dihydro-2-oxo-1h-quinolin-6-yl)-2-(4-(2-phenylethyl)piperidin-1-yl)-ethanol or -ethanone and pharmaceutical compositions | |
| IL99501A0 (en) | Interleukin 9 receptors,methods for the use thereof and pharmaceutical compositions containing the same | |
| EP0474129A3 (en) | 1,4-dihydropyridine derivatives and process for preparing the same | |
| EP0714890A3 (de) | Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin | |
| HUT74615A (en) | 2,3-cyclic-condensed-1,4-dihydro-pyridine derivatives, process for producing them and pharmaceutical compositions containing the same | |
| NZ234395A (en) | 4-(1,2-dihydro-2-oxo-3-pyridyl) chroman derivatives, preparatory processes and pharmaceutical compositions | |
| NZ225303A (en) | 2,5 dialkyl-3-phenyl piperidine derivatives and pharmaceutical compositions | |
| IL105774A (en) | N-(substituted 2-pyridyl)-6-chloro-4-hydroxy-2-methyl-2h-thieno 2, 3-e9-1, 2-thiazine-3-carboxamide, 1, 1-dioxides their preparation and pharmaceutical compositions containing them | |
| NZ234369A (en) | 6-(naphthalenylethyl)-4-hydroxy-pyran-2-one derivatives and the 3,5-dihydroxyheptanoates; pharmaceutical compositions | |
| PH23436A (en) | 1,4-dihydropyridine derivatives,in optically active or racemate form and their pharmaceutical compositions | |
| HU9202914D0 (en) | 4-(4-(4-hydroxiphenyl)-1-piperazinyl)-5-methyl-3h-1,2,4-triazole-3-one derivatives | |
| IL98695A0 (en) | 1,4-disubstituted piperazines,their preparation and pharmaceutical compositions containing them | |
| IL95210A0 (en) | 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same | |
| NZ237442A (en) | 1,6,7,9-tetrahydroxy-11-oxolabdane derivatives; their preparation and pharmaceutical compositions | |
| IL98911A0 (en) | 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them |